Riskpilot← Back to searchSign inGet full accessCellectricon AB
ABActiveOrg 5566020896Neongatan 4 BResearch and experimental development on natural sciences and engineering · NACE 7210Est. 200020-49 employees
Revenue 2024
SEK 28,8M
-2% vs 2023
EBITDA margin
18.0%
-42% vs 2023
Equity ratio
49.2%
Financial strength
Net profit 2024
SEK -123K
-141% vs 2023
| Revenue | SEK 28,8M | -2% |
| EBITDA | SEK 5,2M | -42% |
| Net profit | SEK -123K | -141% |
| Total assets | SEK 24,1M | +6% |
| Equity | SEK 11,9M | +31% |
| Employees | — | — |
Legal name
Cellectricon AB
Org number
5566020896
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
13 december 2000
Share capital
SEK 841 000
Employees
20-49
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva forskning, utveckling och marknadsföring av produkter och metoder inom områdena kemi och medicin, för egen räkning bedriva handel med värdepapper och liknande rättigheter och instrument, samt idka därmed förenlig verksamhet.
Address
Neongatan 4 B
Email
kristina.hillskar@cellectricon.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 8 550 | 11 193 | 15 370 | 19 087 | 14 291 | 17 604 | 29 448 | 28 784 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −6 801 | −10 739 | 1 124 | 949 | 1 533 | 3 844 | 1 881 | 3 539 | 8 977 | 5 172 |
| Depreciation & amort. | −1 079 | −1 069 | −828 | −677 | −1 498 | −2 629 | −2 150 | −2 248 | −3 266 | −2 252 |
| EBIT | −7 880 | −11 808 | 296 | 272 | 35 | 1 215 | −269 | 1 291 | 5 711 | 2 920 |
| Net financials | −170 | −323 | −569 | −201 | −281 | −270 | 42 | −116 | −237 | −140 |
| Profit before tax | −8 050 | −12 131 | −273 | 71 | −247 | 945 | −228 | 1 177 | −27 | −120 |
| Tax | −0 | −0 | −0 | −0 | −0 | −133 | −0 | −209 | −24 | −3 |
| Net profit | −8 050 | −12 131 | −273 | 71 | −247 | 812 | −228 | 968 | −51 | −123 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 10 407 | 12 845 | 12 824 | 14 517 | 15 645 | 13 071 | 15 662 | 17 944 | 22 680 | 24 139 |
| Equity | 2 678 | 2 547 | 2 274 | 2 344 | 2 098 | 2 910 | 2 682 | 3 650 | 9 099 | 11 876 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 6 500 | 6 500 | 6 500 | 6 500 | 3 500 |
| Short-term debt | 7 729 | 10 298 | 10 550 | 12 173 | 13 547 | 3 662 | 6 480 | 7 794 | 7 081 | 8 763 |
| Total debt | 7 729 | 10 298 | 10 550 | 12 173 | 13 547 | 10 162 | 12 980 | 14 294 | 13 581 | 12 263 |
EBITDA margin
18.0%
This company
15.8%
Market median
+14% vs market
20152024
Equity ratio
49.2%
This company
38.2%
Market median
+29% vs market
20152024
Return on equity
-1.0%
This company
18.4%
Market median
-105% vs market
20152024
Net profit margin
-0.4%
This company
8.1%
Market median
-105% vs market
20152024
Asset turnover
1.19×
This company
1.12×
Market median
+6% vs market
20152024
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NM | Audit | 2020 | — | — |
JE Chief Auditor | Chief Auditor | 2020 | — | — |
SM Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Ägir Invest Aktiebolag | Company | 96.0% | 96.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dunross & Co Aktiebolag
Cellectricon AB Board members of Cellectricon AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Magnus Götenfelt | Audit | 0 companies |
| Johan Erik Olof Brobäck | Chief Auditor | 0 companies |
| Sven Mathias Karlsson | Chief Executive Officer | 0 companies |
| Peter Mikael Juhnke | Board of Directors | 0 companies |
| Leif Richard Nilsson | Chairman | 0 companies |
| Erik Jonas Kullgren | Board of Directors | 0 companies |
| Pia Kristina Hillskär | Board of Directors | 0 companies |